Artemis Therapeutics Inc.

ATMSOTCFinancial Services

$0.50

$-1.39(-73.65%)

Market Cap$55792932

P/E Ratio—

52W High$4.5

52W Low$0.1121

Avg Volume1K

Open$0.50

Beta0.00

Net Income Financials Revenue

Artemis Therapeutics Inc. (ATMS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ATMS · net income · updated Jun 9, 2026

Core profitability metrics

ATMS · net income · margin · TTM · CAGR

Net income was −$1.4M for FY2022 (fiscal year ending 2022-12-31), down 650.6% year-over-year. Net profit margin was -434.4%. Based on available data, Artemis Therapeutics Inc. has been profitable since at least 2010.

FY2022 Net Income−$1.4M▼ -650.6% YoY

Trailing 12M (TTM)−$737,000trailing 4 quarters sum

Net Profit Margin-434.4%−$1.4M ÷ $311,000

YoY Change-650.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2010

▸ FMP /income-statement · Annual · ATMS net income history · ATMS profit margin

Annual net income data

ATMS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2022Loss−$1.4M▼ 650.6%-434.4%$311,000

FY2021Loss−$180,000▼ 48.8%—$0

FY2020Loss−$121,000▲ +0.0%—$0

FY2019Loss−$121,000▼ 123.6%—$0

FY2018$513,000▲ +144.9%198.1%$259,000

Net income vs peers (Financial Services)

ATMS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Artemis Therapeutics Inc.YOU

ATMS

−$1.4M-650.6%-434.4%

Loss

Berkshire Hathaway Inc.

BRK-B

$66.97B-24.8%18.0%

100%

Berkshire Hathaway Inc.

Mastercard Incorporated

$14.97B+16.3%45.6%

22%

Financial Services · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Artemis Therapeutics Inc. (ATMS) reported net income of −$1.4M for FY2022 (fiscal year ending 2022-12-31), down 650.6% year-over-year. The net profit margin was -434.4% — meaning the company kept $-4.34 of every dollar of revenue as profit.

Based on available data, Artemis Therapeutics Inc. has been profitable since at least 2010. Net income reached a peak of $4.9M in FY2010. Data available for 15 fiscal years.

Artemis Therapeutics Inc.'s net profit margin was -434.4% for FY2022, based on the latest annual results.

Investors sometimes search for "Artemis Therapeutics Inc. net worth" — the company's market capitalization is a separate figure from ATMS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ATMS net income · 4 questions

Artemis Therapeutics Inc. is not currently profitable on an annual basis. The company reported a net loss of $1.4M for FY2022.

is ATMS profitabledoes ATMS make a profitATMS profitabilityATMS profitable company

▸ Source: FMP /income-statement · GAAP · Artemis Therapeutics Inc. · Artemis Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026